Brokerages Set Adient (NYSE:ADNT) Target Price at $22.88

Adient (NYSE:ADNT) has been given an average rating of “Reduce” by the eleven brokerages that are covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $23.1250.

ADNT has been the subject of several analyst reports. Stifel Nicolaus initiated coverage on Adient in a research report on Thursday, August 21st. They set a “buy” rating and a $27.00 price objective for the company. Morgan Stanley boosted their price objective on Adient from $16.00 to $17.00 and gave the stock an “underweight” rating in a research report on Tuesday, August 12th. Weiss Ratings reiterated a “sell (d)” rating on shares of Adient in a research report on Wednesday, October 8th. Wall Street Zen upgraded Adient from a “hold” rating to a “buy” rating in a research report on Friday, July 18th. Finally, Bank of America boosted their target price on Adient from $17.50 to $20.00 and gave the stock an “underperform” rating in a report on Wednesday, September 10th.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of ADNT. Greenwich Wealth Management LLC increased its stake in Adient by 1.3% in the 2nd quarter. Greenwich Wealth Management LLC now owns 35,211 shares of the company’s stock valued at $685,000 after buying an additional 435 shares during the last quarter. Covestor Ltd increased its stake in Adient by 15.2% in the 1st quarter. Covestor Ltd now owns 6,984 shares of the company’s stock valued at $90,000 after buying an additional 922 shares during the last quarter. Yousif Capital Management LLC increased its stake in Adient by 3.1% in the 2nd quarter. Yousif Capital Management LLC now owns 37,363 shares of the company’s stock valued at $727,000 after buying an additional 1,114 shares during the last quarter. SummerHaven Investment Management LLC increased its stake in Adient by 3.6% in the 2nd quarter. SummerHaven Investment Management LLC now owns 34,411 shares of the company’s stock valued at $670,000 after buying an additional 1,204 shares during the last quarter. Finally, GAMMA Investing LLC increased its stake in Adient by 157.5% in the 1st quarter. GAMMA Investing LLC now owns 2,235 shares of the company’s stock valued at $29,000 after buying an additional 1,367 shares during the last quarter. Institutional investors own 92.44% of the company’s stock.

Adient Stock Performance

Shares of ADNT stock opened at $22.40 on Friday. The company has a quick ratio of 0.92, a current ratio of 1.12 and a debt-to-equity ratio of 1.15. The business has a 50 day moving average of $24.08 and a two-hundred day moving average of $19.21. Adient has a 52 week low of $10.04 and a 52 week high of $26.16. The company has a market cap of $1.82 billion, a P/E ratio of -8.45, a PEG ratio of 0.75 and a beta of 1.77.

Adient (NYSE:ADNT) last issued its earnings results on Wednesday, May 31st. The company reported ($0.13) EPS for the quarter. Adient had a negative net margin of 1.53% and a positive return on equity of 8.25%. The company had revenue of $3.51 billion during the quarter. As a group, analysts anticipate that Adient will post 1.76 EPS for the current year.

Adient Company Profile

Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.